Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Iovanna

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Translational Oncology|November 28, 2020
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancerJuan Iovanna
Medecine Sciences : M/S|February 5, 2020
[Organoids from pancreatic ductal adenocarcinoma]Nelson Dusetti, Juan Iovanna
Medicina|July 29, 2022
[An "a la carte" treatment for patients with pancreatic adenocarcinoma]Juan Iovanna, Nelson Dusetti
Cancer Letters|September 27, 2017
Speeding towards individualized treatment for pancreatic cancer by taking an alternative roadJuan Iovanna, Nelson Dusetti
Critical Reviews in Oncology/Hematology|January 8, 2026
Why isn't an oncogenic mutation in KRAS enough to induce and sustain transformation?Juan Iovanna, Nelson Dusetti
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 31, 2021
Combating pancreatic cancer chemoresistance by triggering multiple cell death pathwaysPatricia Santofimia-Castaño, Juan Iovanna
Frontiers in Oncology|February 11, 2020
Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic AdenocarcinomaMirna Swayden, Philippe Soubeyran, Juan Iovanna
Heliyon|December 25, 2018
Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotypeMirna Swayden, Juan Iovanna, Philippe Soubeyran
Critical Reviews in Oncology/Hematology|April 10, 2026
When Defense Turns Dangerous: The Dual Nature of Senescence in Pancreatic Ductal AdenocarcinomaJuan Iovanna, Nelson Dusetti, Daniel Grasso
Cancers|August 7, 2021
NUPR1: A Critical Regulator of the Antioxidant SystemCan Huang, Patricia Santofimia-Castaño, Juan Iovanna
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Translational Oncology|November 28, 2020
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancerJuan Iovanna
Medecine Sciences : M/S|February 5, 2020
[Organoids from pancreatic ductal adenocarcinoma]Nelson Dusetti, Juan Iovanna
Medicina|July 29, 2022
[An "a la carte" treatment for patients with pancreatic adenocarcinoma]Juan Iovanna, Nelson Dusetti
Cancer Letters|September 27, 2017
Speeding towards individualized treatment for pancreatic cancer by taking an alternative roadJuan Iovanna, Nelson Dusetti
Critical Reviews in Oncology/Hematology|January 8, 2026
Why isn't an oncogenic mutation in KRAS enough to induce and sustain transformation?Juan Iovanna, Nelson Dusetti
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 31, 2021
Combating pancreatic cancer chemoresistance by triggering multiple cell death pathwaysPatricia Santofimia-Castaño, Juan Iovanna
Frontiers in Oncology|February 11, 2020
Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic AdenocarcinomaMirna Swayden, Philippe Soubeyran, Juan Iovanna
Heliyon|December 25, 2018
Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotypeMirna Swayden, Juan Iovanna, Philippe Soubeyran
Critical Reviews in Oncology/Hematology|April 10, 2026
When Defense Turns Dangerous: The Dual Nature of Senescence in Pancreatic Ductal AdenocarcinomaJuan Iovanna, Nelson Dusetti, Daniel Grasso
Cancers|August 7, 2021
NUPR1: A Critical Regulator of the Antioxidant SystemCan Huang, Patricia Santofimia-Castaño, Juan Iovanna
Pageof 15